Nancy M. Bennett

23.3k total citations · 6 hit papers
126 papers, 10.4k citations indexed

About

Nancy M. Bennett is a scholar working on Epidemiology, General Health Professions and Microbiology. According to data from OpenAlex, Nancy M. Bennett has authored 126 papers receiving a total of 10.4k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Epidemiology, 28 papers in General Health Professions and 18 papers in Microbiology. Recurrent topics in Nancy M. Bennett's work include Respiratory viral infections research (49 papers), Influenza Virus Research Studies (47 papers) and Pneumonia and Respiratory Infections (41 papers). Nancy M. Bennett is often cited by papers focused on Respiratory viral infections research (49 papers), Influenza Virus Research Studies (47 papers) and Pneumonia and Respiratory Infections (41 papers). Nancy M. Bennett collaborates with scholars based in United States, Kenya and Australia. Nancy M. Bennett's co-authors include Cynthia G. Whitney, Arthur Reingold, Monica M. Farley, Tamara Pilishvili, Lee H. Harrison, Ann Thomas, Ruth Lynfield, William Schaffner, James L. Hadler and Anne Schuchat and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Nancy M. Bennett

122 papers receiving 10.0k citations

Hit Papers

Decline in Invasive Pneumococcal Disease after the Introd... 2003 2026 2010 2018 2003 2009 2006 2011 2014 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine
    2003 1.7k citations Cynthia G. Whitney, Monica M. Farley et al. profile →
  2. Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine
    2009 1.0k citations Tamara Pilishvili, Catherine Lexau et al. profile →
  3. Effect of Introduction of the Pneumococcal Conjugate Vaccine on Drug-Resistant Streptococcus pneumoniae
    2006 653 citations Ruth Lynfield, William Schaffner et al. profile →
  4. Bacterial Meningitis in the United States, 1998–2007
    2011 632 citations Cynthia G. Whitney, Elizabeth R. Zell et al. profile →
  5. Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices.
    2014 549 citations Sara Tomczyk, Nancy M. Bennett et al. PubMed profile →
  6. Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study
    2006 503 citations Cynthia G. Whitney, Monica M. Farley et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nancy M. Bennett United States 45 8.5k 3.3k 1.2k 1.2k 744 126 10.4k
Kim Mulholland United Kingdom 49 6.6k 0.8× 2.7k 0.8× 1.5k 1.3× 1.3k 1.2× 871 1.2× 279 10.1k
Ann Thomas United States 46 7.7k 0.9× 2.9k 0.9× 1.2k 1.0× 1.5k 1.3× 427 0.6× 145 9.4k
Elizabeth R. Zell United States 48 7.0k 0.8× 2.8k 0.9× 1.8k 1.5× 2.6k 2.3× 1.4k 1.9× 128 10.4k
Steven Black United States 51 8.8k 1.0× 3.6k 1.1× 2.5k 2.1× 800 0.7× 2.3k 3.1× 209 12.6k
Peter McIntyre Australia 52 7.5k 0.9× 4.1k 1.3× 2.4k 2.1× 827 0.7× 2.5k 3.4× 389 10.7k
J. Anthony G. Scott United Kingdom 47 4.2k 0.5× 1.1k 0.3× 1.2k 1.0× 1.2k 1.0× 571 0.8× 160 7.5k
Allen S. Craig United States 39 5.7k 0.7× 2.4k 0.8× 1.7k 1.4× 2.5k 2.1× 315 0.4× 88 8.6k
Maria Deloria Knoll United States 38 6.1k 0.7× 2.8k 0.9× 2.0k 1.6× 624 0.5× 1.4k 1.9× 124 8.6k
Shamez Ladhani United Kingdom 61 7.3k 0.9× 4.4k 1.4× 3.6k 3.0× 2.2k 1.9× 1.1k 1.4× 382 14.4k
Henry R. Shinefield United States 52 7.9k 0.9× 3.2k 1.0× 2.3k 1.9× 871 0.8× 1.6k 2.2× 176 11.5k

Countries citing papers authored by Nancy M. Bennett

Since Specialization
Citations

This map shows the geographic impact of Nancy M. Bennett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy M. Bennett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy M. Bennett more than expected).

Fields of papers citing papers by Nancy M. Bennett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy M. Bennett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy M. Bennett. The network helps show where Nancy M. Bennett may publish in the future.

Co-authorship network of co-authors of Nancy M. Bennett

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy M. Bennett. A scholar is included among the top collaborators of Nancy M. Bennett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy M. Bennett. Nancy M. Bennett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Cullen, John P., et al.. (2023). Addressing COVID-19 vaccine hesitancy in rural communities: A case study in engaging trusted messengers to pivot and plan. Frontiers in Public Health. 11. 9 indexed citations
3.
Yousefi‐Nooraie, Reza, et al.. (2023). Mapping the distribution of health equity research and practice across a university: a network analysis. Journal of Clinical and Translational Science. 7(1). e142–e142.
4.
Gargano, Julia W., Nancy McClung, Rayleen M. Lewis, et al.. (2022). HPV type‐specific trends in cervical precancers in the United States, 2008 to 2016. International Journal of Cancer. 152(2). 137–150. 19 indexed citations
5.
Chow, Eric J., Melissa A. Rolfes, Alissa O’Halloran, et al.. (2020). Acute Cardiovascular Events Associated With Influenza in Hospitalized Adults. Annals of Internal Medicine. 173(8). 605–613. 86 indexed citations
6.
Milucky, Jennifer, Nadine Rouphael, Nancy M. Bennett, et al.. (2019). Streptococcus pneumoniae colonization after introduction of 13-valent pneumococcal conjugate vaccine for US adults 65 years of age and older, 2015–2016. Vaccine. 37(8). 1094–1100. 22 indexed citations
7.
Pondo, Tracy, Lesley McGee, Monica M. Farley, et al.. (2019). Early Impact of 13-Valent Pneumococcal Conjugate Vaccine Use on Invasive Pneumococcal Disease Among Adults With and Without Underlying Medical Conditions—United States. Clinical Infectious Diseases. 70(12). 2484–2492. 51 indexed citations
8.
MacNeil, Jessica R., Nancy M. Bennett, Monica M. Farley, et al.. (2015). Epidemiology of Infant Meningococcal Disease in the United States, 2006-2012. PEDIATRICS. 135(2). e305–e311. 32 indexed citations
9.
Reed, Carrie, Sandra S. Chaves, Pam Daily Kirley, et al.. (2015). Estimating Influenza Disease Burden from Population-Based Surveillance Data in the United States. PLoS ONE. 10(3). e0118369–e0118369. 263 indexed citations
10.
Hariri, Susan, Elizabeth R. Unger, Sean Schafer, et al.. (2014). HPV Type Attribution in High-Grade Cervical Lesions: Assessing the Potential Benefits of Vaccines in a Population-Based Evaluation in the United States. Cancer Epidemiology Biomarkers & Prevention. 24(2). 393–399. 39 indexed citations
11.
Tomczyk, Sara, Nancy M. Bennett, Charles Stoecker, et al.. (2014). Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices.. PubMed. 63(37). 1069–1075. 549 indexed citations breakdown →
12.
Bennett, Nancy M., et al.. (2013). Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Children Aged 6–18 Years with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morbidity and Mortality Weekly Report. 62(25). 521–524. 123 indexed citations
13.
Oza‐Frank, Reena, Elizabeth R. Zell, Ruth Link‐Gelles, et al.. (2012). Epidemiology of Invasive Pneumococcal Disease Among High-Risk Adults Since the Introduction of Pneumococcal Conjugate Vaccine for Children. Clinical Infectious Diseases. 56(5). e59–e67. 71 indexed citations
14.
Dawood, Fatimah S., Anthony E. Fiore, Laurie Kamimoto, et al.. (2010). Influenza-Associated Pneumonia in Children Hospitalized With Laboratory-Confirmed Influenza, 2003–2008. The Pediatric Infectious Disease Journal. 29(7). 585–590. 50 indexed citations
15.
Dawood, Fatimah S., Anthony E. Fiore, Laurie Kamimoto, et al.. (2010). Burden of Seasonal Influenza Hospitalization in Children, United States, 2003 to 2008. The Journal of Pediatrics. 157(5). 808–814. 92 indexed citations
16.
O’Brien, Katherine L., Orin S. Levine, Cynthia G. Whitney, et al.. (2006). Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study.(Clinical report). The Lancet. 368(9546). 61 indexed citations
17.
Fontanesi, John, et al.. (2006). Mass vaccination clinics versus appointments.. PubMed. 21(5). 288–94. 8 indexed citations
18.
Forsyth, J.R.L., et al.. (2003). The Year of the Salmonella Seekers—1977. Australian and New Zealand Journal of Public Health. 27(4). 385–389. 6 indexed citations
19.
Beneden, Chris Van, Catherine Lexau, Wendy Baughman, et al.. (2003). Aggregated Antibiograms and Monitoring of Drug-ResistantStreptococcus pneumoniae. Emerging infectious diseases. 9(9). 1089–1095. 24 indexed citations
20.
Mukamel, Dana B., Heather T. Gold, & Nancy M. Bennett. (2001). Cost utility of public clinics to increase pneumococcal vaccines in the elderly. American Journal of Preventive Medicine. 21(1). 29–34. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kim Mulholland Breakdown of academic impact, for papers by Ann Thomas Breakdown of academic impact, for papers by Elizabeth R. Zell Breakdown of academic impact, for papers by Steven Black Breakdown of academic impact, for papers by Peter McIntyre Breakdown of academic impact, for papers by J. Anthony G. Scott Breakdown of academic impact, for papers by Allen S. Craig Breakdown of academic impact, for papers by Maria Deloria Knoll Breakdown of academic impact, for papers by Shamez Ladhani Breakdown of academic impact, for papers by Henry R. Shinefield
Rankless by CCL
2026